Winters Chad 4
4 · WEST PHARMACEUTICAL SERVICES INC · Filed Feb 20, 2025
Insider Transaction Report
Form 4
Winters Chad
VP, Chief Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
2025-02-18$211.00/sh+82.054$17,313→ 1,390.752 total - Tax Payment
Common Stock
2025-02-18$211.00/sh−27.727$5,850→ 1,363.025 total - Award
Stock Option (Right to Buy)
2025-02-18+822→ 822 totalExercise: $211.00From: 2026-02-18Exp: 2035-02-18→ Common Stock (822 underlying) - Award
Rst. Stock Unit
2025-02-18+356→ 356 totalExercise: $0.00→ Common Stock (356 underlying)
Footnotes (1)
- [F1]This award vests in four equal installments beginning on February 18, 2026.